[PHARMA] YoY Quarter Result on 31-Mar-2015 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- -13.36%
YoY- 21.27%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 617,923 618,294 559,195 471,904 468,672 500,339 446,745 5.55%
PBT 28,707 27,777 26,538 38,612 38,159 36,924 42,955 -6.49%
Tax -11,118 -8,519 -8,068 -6,686 -11,513 -11,771 -13,894 -3.64%
NP 17,589 19,258 18,470 31,926 26,646 25,153 29,061 -8.02%
-
NP to SH 17,586 18,923 18,379 31,794 26,217 24,771 28,685 -7.82%
-
Tax Rate 38.73% 30.67% 30.40% 17.32% 30.17% 31.88% 32.35% -
Total Cost 600,334 599,036 540,725 439,978 442,026 475,186 417,684 6.22%
-
Net Worth 524,838 544,360 515,906 528,173 515,022 484,829 474,161 1.70%
Dividend
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Div 12,991 10,368 10,354 18,123 10,352 8,825 8,824 6.65%
Div Payout % 73.87% 54.79% 56.34% 57.00% 39.49% 35.63% 30.76% -
Equity
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Net Worth 524,838 544,360 515,906 528,173 515,022 484,829 474,161 1.70%
NOSH 259,821 259,219 258,859 258,908 258,805 117,676 117,657 14.10%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin 2.85% 3.11% 3.30% 6.77% 5.69% 5.03% 6.51% -
ROE 3.35% 3.48% 3.56% 6.02% 5.09% 5.11% 6.05% -
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 237.83 238.52 216.02 182.27 181.09 425.18 379.70 -7.49%
EPS 6.77 7.30 7.10 12.28 10.13 21.05 24.38 -19.22%
DPS 5.00 4.00 4.00 7.00 4.00 7.50 7.50 -6.53%
NAPS 2.02 2.10 1.993 2.04 1.99 4.12 4.03 -10.86%
Adjusted Per Share Value based on latest NOSH - 258,908
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 42.87 42.90 38.80 32.74 32.52 34.72 31.00 5.54%
EPS 1.22 1.31 1.28 2.21 1.82 1.72 1.99 -7.82%
DPS 0.90 0.72 0.72 1.26 0.72 0.61 0.61 6.69%
NAPS 0.3642 0.3777 0.358 0.3665 0.3573 0.3364 0.329 1.70%
Price Multiplier on Financial Quarter End Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 -
Price 4.28 4.89 5.76 6.00 4.46 8.26 5.90 -
P/RPS 1.80 2.05 2.67 3.29 2.46 1.94 1.55 2.52%
P/EPS 63.23 66.99 81.13 48.86 44.03 39.24 24.20 17.35%
EY 1.58 1.49 1.23 2.05 2.27 2.55 4.13 -14.79%
DY 1.17 0.82 0.69 1.17 0.90 0.91 1.27 -1.35%
P/NAPS 2.12 2.33 2.89 2.94 2.24 2.00 1.46 6.41%
Price Multiplier on Announcement Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 16/05/18 16/05/17 13/05/16 18/05/15 14/05/14 15/05/13 03/05/12 -
Price 4.07 4.72 5.60 6.91 4.70 9.26 5.90 -
P/RPS 1.71 1.98 2.59 3.79 2.60 2.18 1.55 1.65%
P/EPS 60.13 64.66 78.87 56.27 46.40 43.99 24.20 16.37%
EY 1.66 1.55 1.27 1.78 2.16 2.27 4.13 -14.08%
DY 1.23 0.85 0.71 1.01 0.85 0.81 1.27 -0.53%
P/NAPS 2.01 2.25 2.81 3.39 2.36 2.25 1.46 5.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment